Oct 2026· Journal of Antimicrobial Chemotherapy· Vol 81 11· 0 citations· 22 references
Medicine
TL;DR
It is argued that the decision to start, continue or stop antibiotics must remain basically clinical; that the detection of nucleic acids is not equivalent to the diagnosis of an infection; and that sample quality, colonization, contamination, off-panel pathogens and prior antibiotic exposure may mitigate the interpretation of molecular results.
Abstract
Over the past decade, molecular diagnostics have become widespread in clinical microbiology, a trend accelerated by the COVID-19 pandemic. Syndromic multiplex PCR panels are increasingly incorporated into routine practice and clinical guidelines, owing to their speed and ease of use. However, their expanding success may overshadow some fundamental principles in bacteriology. In this viewpoint, we argue that the decision to start, continue or stop antibiotics must remain basically clinical; that the detection of nucleic acids is not equivalent to the diagnosis of an infection; and that sample quality, colonization, contamination, off-panel pathogens and prior antibiotic exposure may mitigate the interpretation of molecular results. Available trials show that rapid molecular diagnostics can improve antimicrobial prescribing but their impact on clinical outcomes appears conditional on integration with stewardship programmes. Molecular diagnostics should accelerate and refine clinical reasoning, rather than stand for the key element in the decision to treat bacterial infections.
Syndromic testing, defined as the simultaneous nucleic acid amplification-based detection of multiple potential pathogens and antimicrobial resistance (AMR) determinants directly from clinical specimens, has transformed laboratory diagnosis of infectious diseases in the United States over the past two decades. In contr...
Caring about the clinical impact of laboratory results, beyond their technical performance, has been part of the clinical microbiologist's mission since the very origins of the discipline. The term diagnostic stewardship is more recent, emerging from a renewed need created by powerful new diagnostic technologies: as te...
A. Mizrahi, C. Burucoa, J. Le Goff et al.· Clinical Microbiology and In...· 0 citations
ASPIRE workflow is a novel, cutting-edge, rapid, and universal Sepsis diagnostic workflow that can identify pathogens and characterize their AMR, directly from whole blood within a clinically actionable TAT, within 6 to 8 hours using nanopore sequencing.
Ramya Vm, T. Hall, D. Sharma et al.· Clinical Chemistry· 0 citations
Objective: to critically evaluate emerging technologies for antimicrobial resistance (AMR) detection in clinical microbiology, highlighting their applications, advantages, and limitations. Methodology: a systematic literature review was conducted following PRISMA guidelines. Searches were performed in the PubMed/MEDLIN...
Thaynara Da Silva Brilhante, Raquel Gadelha Rafael, Vittoria Gabriele Vasconcelos Martins et al.· Journal of Health & Biol...· 0 citations
Pneumonia infections pose a significant global health challenge, accounting for more than 1.2 million emergency department visits and 41,000 deaths in the U.S. annually. Given the low vaccination rates, significant increase in childhood cases over the last couple years, and that untreated infections can result in...
Jason D. Dapper, Stephanie L. Carnes· Clinical Chemistry· 0 citations